Biomarin Pharmaceutical (BMRN) Treasury Shares (2010 - 2025)
Biomarin Pharmaceutical (BMRN) posted Treasury Shares of $513878.0 for Q4 2025, down 88.67% on a QoQ basis from $4.5 million in Q4 2024, and down 88.67% year-over-year from $4.5 million in Q4 2024.
Biomarin Pharmaceutical (BMRN) Treasury Shares (2010 - 2025) Analysis & Trends
Biomarin Pharmaceutical's Treasury Shares history runs 16 years deep, the most recent figure standing at $513878.0 for Q4 2025.
- Quarterly Treasury Shares fell 88.67% year-over-year to $513878.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $513878.0 (down 88.67% YoY) and the FY2025 annual result came in at $513878.0, down 88.67% from the prior year.
- Treasury Shares was $513878.0 for Q4 2025 at Biomarin Pharmaceutical, down from $4.5 million in the prior quarter.
- Across five years, Treasury Shares topped out at $4.5 million in Q4 2024 and bottomed at $92410.0 in Q1 2021.
- A 5-year average of $1.1 million and a median of $442355.5 in 2021 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2024 — Treasury Shares soared 1023.23% — and 2025, when it slumped 88.67%.
- Biomarin Pharmaceutical's Treasury Shares stood at $437049.0 in 2021, then grew by 2.43% to $447662.0 in 2022, then decreased by 9.78% to $403900.0 in 2023, then surged by 1023.23% to $4.5 million in 2024, then slumped by 88.67% to $513878.0 in 2025.
- Business Quant data shows BMRN's Treasury Shares at $513878.0 in Q4 2025, $4.5 million in Q4 2024, and $403900.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Biomarin Pharmaceutical | 11.33 Bn | 9.11 Bn | 571.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 513,878.00 |
| Dec 31, 2025 | 513,878.00 |
| Dec 31, 2024 | 4.54 Mn |
| Dec 31, 2024 | 4.54 Mn |
| Dec 31, 2023 | 403,900.00 |
| Dec 31, 2023 | 403,900.00 |
| Dec 31, 2022 | 447,662.00 |
| Dec 31, 2022 | 447,662.00 |
| Dec 31, 2021 | 437,049.00 |
| Dec 31, 2021 | 437,049.00 |
| Mar 31, 2021 | 92,410.00 |
| Mar 31, 2021 | 92,410.00 |
| Dec 31, 2020 | 220,990.00 |
| Dec 31, 2020 | 220,990.00 |
| Mar 31, 2020 | 126,710.00 |
| Mar 31, 2020 | 126,710.00 |
| Dec 31, 2019 | 44,260.00 |
| Dec 31, 2019 | 44,260.00 |
| Mar 31, 2019 | 99,010.00 |
| Mar 31, 2019 | 99,010.00 |